Michael Allen Jerman Inhibitor Therapeutics, Inc. (INTI) insider trading activity

INTI Quotes by TradingView

Michael Allen Jerman is Director of Inhibitor Therapeutics, Inc.. Currently has a direct ownership of 80,411 shares of INTI, which is worth approximately $6,432. The most recent transaction as insider was on Apr 01, 2024, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80.4K
0% 3M change
n/a 12M change
Total Value Held $6,432

Michael Allen Jerman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 38.34%
80,411 Common Stock

Also insider at

MIRA
MIRA PHARMACEUTICALS, INC.
Director
TELO
Telomir Pharmaceuticals, Inc.
Director
MAJ

Michael Allen Jerman

Director
Miami, FL

Track Institutional and Insider Activities on INTI

Follow Inhibitor Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INTI shares.

Notify only if

Insider Trading

Get notified when an Inhibitor Therapeutics, Inc. insider buys or sells INTI shares.

Notify only if

News

Receive news related to Inhibitor Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INTI